These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30864953)

  • 1. Cangrelor Bridging Within 6 Months of a Drug-Eluting Stent in a Patient for Emergency Cervical Spine Surgery: A Case Report.
    Hu TY; Peeters SM; Nagasawa DT; Kamdar NV; Brook RP; Sun J; Park S; Moreland NC; Cruz D; Macyszyn L; Press MC
    A A Pract; 2019 Jul; 13(2):69-73. PubMed ID: 30864953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug-Eluting Stent Who Developed Acute Tirofiban-Related Thrombocytopenia.
    Kabadi RA; Danelich IM; Entwistle JW; Marhefka GD; Reeves G; Boyle AJ; Qureshi AM
    Pharmacotherapy; 2019 Apr; 39(4):521-525. PubMed ID: 30644585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.
    Bowman S; Gass J; Weeks P
    Ann Pharmacother; 2019 Feb; 53(2):171-177. PubMed ID: 30132336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Cangrelor Bridge Therapy for a Diagnostic Bronchoscopy With Biopsy.
    Calnan MW; Crawford AN
    J Pharm Pract; 2020 Apr; 33(2):231-235. PubMed ID: 30139291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cangrelor Bridge Therapy for Gastroduodenal Biopsy.
    Cahoon WD; Oswalt AK; Francis KE; Magee LC; Lowe DK
    J Pharm Pract; 2017 Apr; 30(2):270-273. PubMed ID: 27000137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cangrelor: a novel intravenous antiplatelet agent with a questionable future.
    Waite LH; Phan YL; Spinler SA
    Pharmacotherapy; 2014 Oct; 34(10):1061-76. PubMed ID: 25123696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of cangrelor in a complex vascular patient: A case report.
    Presley L
    J Vasc Nurs; 2024 Jun; 42(2):138-140. PubMed ID: 38823974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study.
    Aguilar-Salinas P; Agnoletto GJ; Brasiliense LBC; Santos R; Granja MF; Gonsales D; Aghaebrahim A; Sauvageau E; Hanel RA
    J Neurointerv Surg; 2019 Apr; 11(4):347-351. PubMed ID: 30552167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative Bridging With Glycoprotein IIb/IIIa Inhibitors Versus Cangrelor: Balancing Efficacy and Safety.
    Van Tuyl JS; Newsome AS; Hollis IB
    Ann Pharmacother; 2019 Jul; 53(7):726-737. PubMed ID: 30646761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention.
    Dargham BB; Baskar A; Tejani I; Cui Z; Chauhan S; Sum-Ping J; Weideman RA; Banerjee S
    Cardiovasc Revasc Med; 2019 Sep; 20(9):805-811. PubMed ID: 30579773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series.
    Succar L; Lopez CN; Victor DW; Lindberg SA; Saharia A; Sheth S; Mobley CM
    Pharmacotherapy; 2022 Mar; 42(3):263-267. PubMed ID: 35075688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Intravenous Cangrelor as Antiplatelet Bridge Therapy in a Patient Undergoing Esophageal Dilation Procedure.
    Choxi R; Pillai A; Ahmed S; Jovin IS
    Cardiovasc Revasc Med; 2020 Nov; 21(11S):94-95. PubMed ID: 31932170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief review: coronary drug-eluting stents and anesthesia.
    Dalal AR; D'Souza S; Shulman MS
    Can J Anaesth; 2006 Dec; 53(12):1230-43. PubMed ID: 17142658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Franchi F; Rollini F; Rivas A; Wali M; Briceno M; Agarwal M; Shaikh Z; Nawaz A; Silva G; Been L; Smairat R; Kaufman M; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
    Circulation; 2019 Apr; 139(14):1661-1670. PubMed ID: 30630341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Comparison of Oral P2Y
    Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C
    JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data.
    Tamborini Permunian E; Riva N; Guasti L; Squizzato A
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):625-37. PubMed ID: 25728292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative dual antiplatelet therapy for patients undergoing spine surgery soon after drug eluting stent placement.
    Peeters SM; Nagasawa D; Gaonkar B; Niu T; Tucker A; Attiah M; Babayan D; Moreland N; Yang I; Press MC; Macyszyn L
    Surg Neurol Int; 2021; 12():302. PubMed ID: 34345443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]).
    White HD; Bhatt DL; Gibson CM; Hamm CW; Mahaffey KW; Price MJ; Steg PG; Stone GW; Cortese B; Wilensky M; Deliargyris EN; Liu T; Prats J; Harrington RA
    JACC Cardiovasc Interv; 2015 Mar; 8(3):424-433. PubMed ID: 25703887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cangrelor dose titration using platelet function testing during cerebrovascular stent placement.
    Entezami P; Holden DN; Boulos AS; Paul AR; Field NC; Nourollahzadeh E; Yamamoto J; Dalfino JC
    Interv Neuroradiol; 2021 Feb; 27(1):88-98. PubMed ID: 32611215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cangrelor: a novel P2Y12 receptor antagonist.
    Norgard NB
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1219-30. PubMed ID: 19604122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.